We have re-analyzed previously published gene expression data from ninety-four pancreatic ductal adenocarcinomas (PDAC) samples. We determined the gene expression profile of genes differentially expressed in PDAC compared to non-malignant pancreatic tissue. Using the 100 top-ranked genes, we were able to discriminate between PDAC and non-malignant pancreatic tissue. A hierarchical cluster analysis revealed only a 6 % false discovery rate. The prognostic strength of these discriminative genes was underscored by a SVM classification and 3-fold cross validation with an 89 % correct class assignment. The annotation of the 100 top-ranked genes revealed that most of the genes were involved in the processes of signal transduction, cell adhesion, e...
Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer death in the US. Despit...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive types of cancer with a 5-year ...
Currently, prognostication for pancreatic ductal adenocarcinoma (PDAC) is based upon a coarse clinic...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis of...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
Pancreatic cancer is the fifth leading cause of cancer death in the United States. We used cDNA micr...
Abstract Background Pancreatic duct adenocarcinoma (PDAC) remains a major health problem because con...
Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer death in the US. Despit...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive types of cancer with a 5-year ...
Currently, prognostication for pancreatic ductal adenocarcinoma (PDAC) is based upon a coarse clinic...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis of...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
<p>Late diagnosis and systemic dissemination essentially contribute to the invariably poor prognosis...
Pancreatic cancer is the fifth leading cause of cancer death in the United States. We used cDNA micr...
Abstract Background Pancreatic duct adenocarcinoma (PDAC) remains a major health problem because con...
Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer death in the US. Despit...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive types of cancer with a 5-year ...
Currently, prognostication for pancreatic ductal adenocarcinoma (PDAC) is based upon a coarse clinic...